{"name":"Mylan Technologies Inc.","slug":"mylan-technologies-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"MR-100A-01","genericName":"MR-100A-01","slug":"mr-100a-01","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"MR-100A-01","genericName":"MR-100A-01","slug":"mr-100a-01","phase":"phase_3","mechanism":"MR-100A-01 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxNME4tM0RzY1c2dTdsN1pmYnplVW1MdlR0LWVIU0cyNG5ET3BuaGlOYWhmcFcxWHNOanZvcVlwMEN2RlhoeG9JTXUtT0JnUGtuWEQ2Y2NMVHpCYUZUZmxWcjBBMUJPUkVGaFZUc1BrRHNPMjdSSFBPa2xVd1VDTi1scHI3dHpVRU41c3lveC1PdEdLRXJqeUhBTkV2Z2tXZ0NKd2VOazA1a3pnWExjTXFoR3d5Yng0Sms3RlBN0gFyQVVfeXFMT3JNMEhrcHJaU0pYUEdXRDRPNXlKb2hfcUNCendlb0tJUmdxUjVURWV3WnQ4Vm9aZ0c1SFpDU0I3VWplUTZod0VTSWNfdjhpQW8wYTcyLUpENElnbWllTWRBME9MSnB1VDg4VWJlZTFGdkNB?oc=5","date":"2026-01-09","type":"patent","source":"Law360","summary":"Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims - Law360","headline":"Mylan, Aurobindo Must Face Generic Drug Price-Fixing Claims - Law360","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxQSTZzQkNGNnk2ZEJMZ05jb0xGT0FSdk9LbmRhYUkzemttbXJuRENYdkZvRGZpSG9rblZ2SkhiNnAyNjJwbjBNa0ZvUkZ2UnN3QzJxYlpTZ3ZoSDFQZ25EbVdNX3BHWjRIYnNveVViU0E2bllMbEo4d3lXcHpsNV9Fbk5ROGoxd3dKQmNfaDZPRi1ZQldTRnRpOWI3YWZJTk0tekE?oc=5","date":"2025-12-31","type":"trial","source":"Bloomberg Law News","summary":"Pharma Patent Trials Loom in 2026 for Wegovy, Covid-Vaccine Tech - Bloomberg Law News","headline":"Pharma Patent Trials Loom in 2026 for Wegovy, Covid-Vaccine Tech","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNNGJIeFVXTnBTTG11dnVYVWl5c1ZSSXpPX0hMbFJXMDBXS2tpODNxYlljcV83MjhCbUpadHZRUl9sRGRaY3p3MzFQRVZjeGxCeXN1N3M1dU5zbVIxam9XNVhwMUJXVzhfMnFzWTQ0bExuM3RrOWQ5dHJnZU9MTUdIcmhReV81TTRaNWtkcm03TjRrNDVvOGd1ckoyTUNCVGJYNmY3SWo0RUNWb0lzV1FNcGdoeEhMeTQ?oc=5","date":"2025-10-30","type":"pipeline","source":"Law Commentary","summary":"Pfizer Faces Lawsuits Over Alleged Link Between Depo-Provera and Brain Tumors - Law Commentary","headline":"Pfizer Faces Lawsuits Over Alleged Link Between Depo-Provera and Brain Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOMXZwcUF2eWNSaHh2MVY4SlVxN25lSVQ4c2VQS3FzYndfdGk5aWFFUXdRZGtYT0IzeEJob3hUSXVZSjlpcU5uRWRnMXBOd3JVakxpRGpLUjdxYmJISGlXN2EwaWtmaGlKTGh6dGIxQXZRSDJ3c3dxckc0MEJNZ0tuMVk1R25aUVlndlVaSTM0X2FuZnBKelpUdmZtcWNCY3JIT0pyRW56aWFRcDdoTVhFaGtZNXNxWHBZQ0dhZWVVX3luNG9yUWxoS1Y1VXRBWFFfUE0wMw?oc=5","date":"2025-10-01","type":"trial","source":"Jones Day","summary":"Federal Circuit: When and How to Patent Around Clinical Trials - Jones Day","headline":"Federal Circuit: When and How to Patent Around Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNZlBvb0hhSkVtRzFWdmpBbVI0TVFRbVhWSlZHRm1YR2tTWVphM29yQjJzdEZ4NmVBcHlPYTJ2bWluc0tET2w1Qm5MR1pPN1liaVRuNGxJYmtpajM2NGROaF9OOEZLOTl0MGZwLXBtSzFSWEtyM1JRc21RaTNvc2FoZkwzS1dJU0I1NEVnS2M0ZmFrcFE?oc=5","date":"2025-07-24","type":"patent","source":"Pharmaceutical Technology","summary":"Novo Nordisk defeated in Wegovy patent dispute by Viatris - Pharmaceutical Technology","headline":"Novo Nordisk defeated in Wegovy patent dispute by Viatris","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNWV9EM25oZEgtNGxyU1lncjN3bG9QdzB2WThGRlhiRmFkNnJ4SEFJS0h4Z04zelhnM1FIcjRQZlFFRENPOHBvM1lNWVl0eGNxOHdTcDhRZHh4TmsxWmNqZnBfM2tDa0FUaE5hdmdidjJKVGVwdEN5T19PY0pwLXFabnFGdWtVUEx5eEJ1Sm5iekE2OTFQQzA5WGd0OV9pcEMyMlc40gG3AUFVX3lxTFA4MWlxYUxJZEVPVWhjSXpBNEk0QmN0Uk1rRXN4VUd6bnMweGlsVENvZ21TZ1BkaS1rVG1vU3RadExHaWUya2o3U1BBbFR3YlVYQldIR2tZU3dLeUx2NXpzWUR5cG00UlJ3MUlyYy03M2UtUUpuOHhzUzJDSUFVVExDXzF2YWtMMDExbzU1UncxWGpBYkxWdm5yVnVVRmozNGhHU1ZUdlFVbDNodkI3Mm5IQXgxZVdDRQ?oc=5","date":"2023-03-21","type":"pipeline","source":"WDTV 5","summary":"Three new tenants join WVU Innovation Corporation at former Mylan plant - WDTV 5","headline":"Three new tenants join WVU Innovation Corporation at former Mylan plant - WDTV 5","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNYW1BcUt1cWZ0LTVpcmRhVkZXbDdvMWh2cl96Q2pFRkFhSmhLRjlfMzAxSFpLMjNfSzZmWTEyNWJuTGFZNGhmamJNRTJGZTByOHFrOGVXS0EydVZoNndKLXhlSGxSX1VqZnFIblcxdHc5YXhPSFR3LXYyQ0NMRGJEUFpXY00?oc=5","date":"2022-10-20","type":"pipeline","source":"WVU John Chambers College of Business and Economics","summary":"Donald E. Panoz - WVU John Chambers College of Business and Economics","headline":"Donald E. Panoz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxObE1KTk50bk9fNnhUaVZXZUNyYjVhVWxwa1VhcWtJcEFodmE2dUR5dUg0dmZJTl9ZblNIX0NGc2FDbnhXWVA3SGVMd0trLW8wLTVReDZ4akVtYW9oTzJWeFBZZFlid2xoOGlvRnQwUkZEYUE4cm1IMEItMGJRSW1NUlRPYkVNNGVpTDZBb3BmRl9ta2IzZDdKS0NyUlhGRXMwa0FjMFIwSkswSmxNMUE2OQ?oc=5","date":"2021-11-12","type":"pipeline","source":"Mintz","summary":"Federal Circuit Affirms Dismissal of Hatch-Waxman Defendants for Lack of Venue and Failure to State a Claim - Mintz","headline":"Federal Circuit Affirms Dismissal of Hatch-Waxman Defendants for Lack of Venue and Failure to State a Claim","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQT1FIQ3F4WU5Jb2Z6aElaR2tLYk1sbHpseldjZ3BtMm1wcDg2N0pLdlVTUjg3cWZhemF5SGN0S3FuRE9kMlhmRV9WVlcxci12LVh3UVFZOU95a2RGZGdxY3F0U2l4c18zbkNjVjhkdEY1VmczVnczSTRKeC1pUk95VXVKM0NVdVlfSDFHNHZKaHM4VTNGZVhfOWdLNTQ0QVRJWnpHUVY1Mk0?oc=5","date":"2021-08-10","type":"pipeline","source":"Mountain State Spotlight","summary":"Morgantown pharmaceutical plant’s fall started long ago - Mountain State Spotlight","headline":"Morgantown pharmaceutical plant’s fall started long ago","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4gFBVV95cUxQLVp0VnpuNXpsU01NZlRYRUx5bGVrVlBmb3BTTnlRZlhpWXNHZ3NFblYwY3hFYTZlSFlsYldsc1ZhUFdXSVpIc1dKbmJqYk42LUtYbDBNR1R4R0Ryd0lJOExLNDFJQ0dyWnZhRW1TYnR6QXczcnROcTE0cl9nY2pRTkN2bF9SYkgtNUxUS0dvQnlER3RIZ1FyVUEzeGEzMjZxeGxmaWVfS0FoZGdKVlktQ1hUUGtNX0xyNnUwNWVQNW0wT3FsNERNNFhMUWhrOGw0NmswYS1pam9LZXJOWngzYkJR?oc=5","date":"2021-07-21","type":"pipeline","source":"dominionpost.com","summary":"Viatris closing small Mylan plant in Vermont; 40 organizations send letter to Biden to save Morgantown plant - dominionpost.com","headline":"Viatris closing small Mylan plant in Vermont; 40 organizations send letter to Biden to save Morgantown plant","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxQZ01sTkVYbkViT3lmT2RkMzhPYWlDcVExcVp0TVpUNUZLaE5VRXh4THZfRGJOWnZCNmlBaGZKcWRQNTctMVUyamNsNFZ4UmEzUVNpWkM2Ulg5c0dWa0taZVplNXVtQW1XdGUwWGR3MzJTU2stT2NDMUlqWGpldmNyNndyS0U1bzlaaFYyTmp0RnhYdFBhVVJQM3FTaF9MNllfb21Xd1lB?oc=5","date":"2021-07-16","type":"pipeline","source":"Fierce Pharma","summary":"Pfizer antes up $345M to settle long-running EpiPen antitrust claims as Viatris case moves ahead - Fierce Pharma","headline":"Pfizer antes up $345M to settle long-running EpiPen antitrust claims as Viatris case moves ahead","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPZFIwOGpHaXVuVjhGWTRiZ01wdmItTXphQmZadTBJZHZKVnJtSkhXUUYweFBhaE8zbWotR2Vqdm9La25Ja3NxNEVsaHlRSVdEeUxCTzRCR3JhRW5IazQ1ODdrMjBFRGlmLUxzNkhzUGxiemVtdGpQTnVvMER0VGNXT1FGWlkwZXZWWXMwNVhmMG93TGxMNFlfekNPR0F4SWtKLVZQclJmUDdNbG1pZFdmdg?oc=5","date":"2019-01-30","type":"pipeline","source":"Bloomberg.com","summary":"Culture of ‘Bending Rules’ in India Challenges U.S. Drug Agency - Bloomberg.com","headline":"Culture of ‘Bending Rules’ in India Challenges U.S. Drug Agency","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}